Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Medacta Group SA
  6. News
  7. Summary
    MOVE   CH0468525222

MEDACTA GROUP SA

(MOVE)
  Report
Delayed Swiss Exchange  -  11:30 2022-08-12 am EDT
97.60 CHF   +0.62%
07/29TRANSCRIPT : Medacta Group SA, H1 2022 Earnings Call, Jul 29, 2022
CI
07/29Medacta Expects to Hit Top End of FY Revenue Guidance After 19% Growth in H1
MT
07/29MEDACTA : 2022 Half-Year Unaudited Top-Line Figures Presentation
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Medacta Group SA Approves Distribution

05/19/2022 | 01:00pm EDT
share with twitter
share with LinkedIn
share with facebook

The Medacta Group SA announced that Annual General Meeting held on May 19, 2022 shareholders approved the distribution of CHF 10.7 million or CHF 0.535 per share, half of it to be distributed as dividend out of available earnings and half of it to be distributed out of accumulated reserves from capital contribution.


© S&P Capital IQ 2022
All news about MEDACTA GROUP SA
07/29TRANSCRIPT : Medacta Group SA, H1 2022 Earnings Call, Jul 29, 2022
CI
07/29Medacta Expects to Hit Top End of FY Revenue Guidance After 19% Growth in H1
MT
07/29MEDACTA : 2022 Half-Year Unaudited Top-Line Figures Presentation
PU
07/29Medacta Group SA reports 19.0% growth of half-year revenue
EQ
07/29Medacta Group SA Announces Unaudited Revenue Results for the First Half Ended June 30, ..
CI
07/29Medacta Group SA Provides Revenue Guidance for the Year 2022
CI
06/23Medacta Announces First Lumbar Fusion Procedure with NextAR Augmented Reality Surgical ..
EQ
05/24MEDACTA : Company Presentation
PU
05/19Medacta Group announces the results of today's Annual General Meeting
EQ
05/19Medacta Group SA Approves Distribution
CI
More news
Analyst Recommendations on MEDACTA GROUP SA
More recommendations
Financials
Sales 2022 427 M 438 M 438 M
Net income 2022 57,0 M 58,4 M 58,4 M
Net Debt 2022 115 M 118 M 118 M
P/E ratio 2022 33,5x
Yield 2022 0,63%
Capitalization 2 017 M 2 069 M 2 069 M
EV / Sales 2022 4,99x
EV / Sales 2023 4,36x
Nbr of Employees 1 341
Free-Float 30,4%
Chart MEDACTA GROUP SA
Duration : Period :
Medacta Group SA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDACTA GROUP SA
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Last Close Price 100,92 €
Average target price 115,60 €
Spread / Average Target 14,5%
EPS Revisions
Managers and Directors
Francesco Siccardi Chief Executive Officer
Corrado Farsetta Chief Financial Officer
Alberto Siccardi Non-Executive Chairman
Victor Waldemar Balli Lead Independent Non-Executive Director
Philippe A. Weber Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
MEDACTA GROUP SA-31.27%2 069
ABBOTT LABORATORIES-20.79%195 226
MEDTRONIC PLC-8.34%125 988
BECTON, DICKINSON AND COMPANY7.29%75 203
HOYA CORPORATION-14.17%39 624
SARTORIUS STEDIM BIOTECH-20.96%36 037